Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 August 2026 - preview of changes for September 2026
|
Pharmaceutical |
Change |
|---|---|
|
Acitretin (Novatretin) cap 10 mg and cap 25 mg |
price increase and addition of PSS |
|
Amino acid formula powder 13.3 g protein, 57 g carbohydrate and 24.6 g fat per 100 g, can, 400 g (Alfamino) and powder 15 g protein, 56 g |
price increase |
|
Amino acid oral feed (Vivonex TEN) powder 11 g protein, 62 g carbohydrate and 1 g fat per sachet, 80 g sachet |
price increase |
|
Amlodipine (Vasorex) tab 2.5 mg, 5 mg and 10 mg |
price increase and addition of PSS |
|
Amoxicillin with clavulanic acid (Curam Duo 500/125) tab 500 mg with clavulanic acid 125 mg |
price increase and addition of PSS |
|
Anastrozole (Anatrole) tab 1 mg |
price increase and addition of PSS |
|
Atazanavir sulphate (Atazanavir Viatris) cap 150 mg and 200 mg |
new Pharmacode listing
|
|
Atropine sulphate (Atropt) eye drops 1%, 15 ml |
price increase and addition of PSS |
|
Betahistine dihydrochloride (Serc) tab 16 mg |
price increase and addition of PSS |
|
Betamethasone dipropionate (Diprosone) crm 0.05% and oint 0.05%, 50 g |
addition of PSS |
|
Benzylpenicillin sodium [Penicillin G] (Sandoz) inj 600 mg (1 million units) vial |
price increase and addition of PSS |
|
Bisoprolol fumarate (Ipca-Bisoprolol) tab 2.5 mg |
addition of PSS |
|
Bisoprolol fumarate (Ipca-Bisoprolol) tab 5 mg and 10 mg |
price increase and addition of PSS
|
|
Bupivacaine hydrochloride inj 2.5 mg per ml, 20 ml ampoule sterile pack (Marcain) and inj 5 mg per ml, 4 ml ampoule (Marcain Isobaric) |
price increase and addition of PSS
|
|
Calcitriol cap 0.25 mcg and 0.5 mcg |
Brand change Calcitriol Devatis – new listing and addition of PSS
Calcitriol XL and Calcitriol-AFT to be |
|
Calcium carbonate (Calci-Tab 500) tab 1.25 g (500 mg elemental) |
price increase and addition of PSS
|
|
Captopril (DP-Captopril) oral liq 5 mg per ml, 100 ml |
price increase and addition of PSS
|
|
Cefazolin (Cefazolin-AFT) inj 500 mg vial |
price increase and addition of PSS |
|
Cefazolin (Cefazolin-AFT) inj 1 g vial and 2 g vial |
addition of PSS |
|
Cetirizine hydrochloride (Histaclear) oral liq 1 mg per ml, 200 ml |
price increase |
|
Chlorhexidine with cetrimide (LumaCina) irrigation soln 0.05% with cetrimide 0.5%, 30 ml ampoule |
new listing (p’code 2735040) |
|
Clarithromycin (Klacid IV) inj 500 mg vial |
price increase and addition of PSS |
|
Clonidine (Mylan) patch 2.5 mg, 100 mcg per day, patch 5 mg, 200 mcg per day and patch 7.5 mg, 300 mcg per day |
price increase and addition of PSS |
|
Cyclizine lactate inj 50 mg per ml, 1 ml ampoule |
Brand change
|
|
Dapsone (Dapsone (Rising)) tab 25 mg |
new listing (p’code 2736284) |
|
Dexmedetomidine inj 100 mcg per ml, 2 ml |
Brand change
|
|
Docusate sodium (Coloxyl) tab 50 mg and 120 mg |
price increase and addition of PSS |
|
Donepezil hydrochloride (Ipca-Donepezil) tab 5 mg and 10 mg |
price increase and addition of PSS
|
|
Droperidol (Droperidol Panpharma) inj 2.5 mg per ml, 1 ml ampoule |
to be delisted 1 December 2026
|
|
Dulaglutide (Trulicity) inj 1.5 mg per 0.5 ml |
amended restriction criteria
|
|
Enoxaparin sodium |
new Pharmacode listing
|
|
Escitalopram (Ipca-Escitalopram) tab 10 mg and 20 mg |
price increase and addition of PSS
|
|
Fentanyl (Biomed) inj 10 mcg per ml, 100 ml bag |
price increase and addition of PSS |
|
Finasteride (Ricit) tab 5 mg |
price increase and addition of PSS |
|
Glucose [Dextrose] (Biomed) inj 50%, 10 ml |
price increase and addition of PSS |
|
Indapamide (Dapa-Tabs) tab 2.5 mg |
price increase and addition of PSS |
|
Isosorbide mononitrate (Duride) tab long-acting 60 mg |
price increase and addition of PSS
|
|
Haemophilus influenzae type B vaccine (Act-HIB) inj 10 mcg vial with diluent syringe |
amended restriction criteria |
|
High arginine oral feed 1.4 kcal/ml (Impact |
price increase |
|
Hydrocortisone and paraffin liquid and lanolin (DP Lotn HC) lotn 1% with paraffin liquid 15.9% and lanolin 0.6%, 250 ml |
price increase and addition of PSS |
|
Hydroxyurea [hydroxycarbamide] (Devatis) cap 500 mg |
price increase and addition of PSS
|
|
Hyoscine butylbromide (Spazmol) inj 20 mg, 1 ml ampoule |
price increase and addition of PSS |
|
Ketamine (Ketalar) inj 100 mg per ml, 2 ml vial |
Pharmacode 436895 delisted 1 September 2026 |
|
Lamivudine
|
price increase and addition of PSS |
|
Lidocaine [lignocaine] hydrochloride with |
new listing (p’code 2736349) |
|
Liraglutide (Victoza) inj 6 mg per ml, 3 ml prefilled pen |
amended restriction criteria |
|
Low electrolyte oral feed 2 kcal/ml (Novasource Renal (Vanilla)) liquid 9.1 g protein, 19 g |
price increase |
|
Low-GI oral feed 1 kcal/ml (Nutren Diabetes |
price increase |
|
Montelukast (Montelukast (Sandoz)) tab 4 mg |
new listing (p’code 2735954) |
|
Morphine sulphate (Biomed) inj 1 mg per ml, 100 ml bag, inj 1 mg per ml, 10 ml syringe and inj 1 mg per ml, 50 ml syringe |
price increase and addition of PSS |
|
Naltrexone hydrochloride (Naltrexone-GH) tab 50 mg |
new listing (p’code 2692961) |
|
Nystatin
|
price increase and addition of PSS
|
|
Olanzapine (APO-Olanzapine) |
new listing
|
|
Oral feed (Sustagen Hospital Formula (Chocolate and Vanilla)) powder 23 g protein, 65 g |
price increase |
|
Paracetamol (Gacet) suppos 125 mg, 250 mg and 500 mg |
price increase and addition of PSS |
|
Paraffin (EVARA White Soft Paraffin) white soft, 450 g |
price decrease and addition of PSS |
|
Perindopril
|
new listing
|
|
Pine tar with trolamine laurilsulfate and fluorescein (Pinetarsol) soln 2.3% with trolamine laurilsulfate and fluorescein sodium, 500 ml |
price increase and addition of PSS
|
|
Poloxamer (Coloxyl) oral drops 10%, 30 ml |
price increase and addition of PSS |
|
Potassium iodate (NeuroTabs) tab 253 mcg (150 mcg elemental iodine) |
price increase and addition of PSS
|
|
Propranolol (Cardinol LA) cap long-acting 160 mg |
to be delisted 1 January 2027 |
|
Protein supplement (Resource Beneprotein) |
price increase |
|
Remifentanil (Remifentanil-AFT) inj 1 mg vial and 2 mg vial |
price increase and addition of PSS
|
|
Ropivacaine hydrochloride (Ropivacaine Kabi)
|
price increase and addition of PSS |
|
SGLT2 Inhibitors |
amended restriction criteria |
|
Sildenafil (Sildenafil (Amarox)) tab 50 mg |
new listing (p’code 2735962) |
|
Tamsulosin hydrochloride (Aurobindo Tamsulosin) cap 400 mcg |
new listing (p’code 2735865) |
|
Temazepam (Normison) tab 10 mg |
price increase and addition of PSS |
|
Terbinafine (Deolate) tab 250 mg |
price increase and addition of PSS |
|
Teriparatide (Teriparatide Teva S29) inj 250 mcg per ml, 2.4 ml |
new listing (p’code 2735768) |
|
Ursodeoxycholic acid (Ursosan) cap 250 mg |
price decrease and addition of PSS |
|
Water inj 20 ml ampoule |
Brand change
|
|
Vitamin B complex (Bplex) tab strong, BPC |
price increase |
|
Zidovudine with lamivudine (Lamivudine/Zidovudine Viatris) tab 300 mg with lamivudine 150 mg |
Pharmacode 2645300 to be delisted 1 |